Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

This study has been completed.
Information provided by:
Sandoz Identifier:
First received: April 13, 2009
Last updated: April 14, 2009
Last verified: April 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2004
  Primary Completion Date: February 2004 (Final data collection date for primary outcome measure)